Abhydrolase domain containing 3, commonly abbreviated as ABHD3, is an enzyme that belongs to the serine hydrolase superfamily and is characterized by its abhydrolase domain. This domain confers the enzyme with the ability to hydrolyze various substrates, including esters and amides. ABHD3 is specifically known to possess phospholipase activity, playing a role in the metabolism of phospholipids which are critical components of cell membranes and serve as signaling molecules in numerous cellular processes.ABHD3's phospholipase activity implicates it in the regulation of lipid signaling pathways and membrane dynamics. It can modify the composition of lipid membranes, influencing membrane fluidity, curvature, and the formation of lipid signaling molecules. This enzymatic activity positions ABHD3 as a modulator of intracellular signaling cascades and cellular responses, such as cell proliferation, migration, and survival.
Expression patterns of ABHD3 are tissue-specific, suggesting that its enzymatic function is relevant to the physiology of certain cell types, potentially including those involved in lipid metabolism such as hepatocytes or adipocytes. Exploring the expression and regulation of ABHD3 can provide insights into its physiological roles and the context in which it operates.Research into ABHD3 often involves characterizing its substrate specificity and the identification of reaction products to understand its metabolic implications better. Genetic studies, such as those using gene knockouts or overexpression systems, can help reveal the consequences of altered ABHD3 activity and its importance in maintaining cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can indirectly influence ABHD3. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
This compound can modulate lipid signaling pathways, possibly impacting ABHD3 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
As a bioactive lipid, it may influence ABHD3 indirectly through sphingolipid metabolism. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPAR-gamma agonist that could indirectly affect ABHD3 by altering lipid metabolic pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another PPAR-gamma agonist, potentially influencing ABHD3 through lipid metabolism modulation. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
A PPAR-delta agonist that may indirectly impact ABHD3's activity in lipid metabolism. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Phosphodiesterase inhibitor that raises cAMP levels, potentially influencing ABHD3 indirectly. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Known to affect lipid metabolism, which could indirectly impact ABHD3's activity. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $90.00 $194.00 | 1 | |
A natural ethanolamide that may influence lipid signaling pathways, affecting ABHD3 activity. | ||||||